Analysis of the Frequency and Outcomes of Transformed Nodular Lymphocyte-Predominant Hodgkin Lymphoma in the United States: A Population-Based Study - Top-Institutions - MDSpire

Analysis of the Frequency and Outcomes of Transformed Nodular Lymphocyte-Predominant Hodgkin Lymphoma in the United States: A Population-Based Study

  • By

  • John L. Vaughn

  • Malak Munir

  • Ashley Cobb

  • Sravani Rimmalapudi

  • Narendranath Epperla

  • April 23, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Hematology
    • Oncology
    • Lymphoma Research

  • #2

    Dana-Farber Cancer Institute
    Dana-Farber Cancer Institute

    Boston, MA

    Key Differentiators

    • Hematology
    • Oncology
    • Cancer Epidemiology

  • #3

    MD Anderson Cancer Center
    MD Anderson Cancer Center

    Houston, TX

    Key Differentiators

    • Hematology
    • Oncology
    • Cancer Genomics

  • #4

    Fred Hutchinson Cancer Center
    Fred Hutchinson Cancer Center

    Seattle, WA

    Key Differentiators

    • Hematology
    • Oncology
    • Stem Cell Transplantation

  • #5

    Johns Hopkins University School of Medicine
    Johns Hopkins University School of Medicine

    Baltimore, MD

    Key Differentiators

    • Hematology
    • Oncology
    • Cancer Biology

Original Source(s)

Analysis of the Frequency and Outcomes of Transformed Nodular Lymphocyte-Predominant Hodgkin Lymphoma in the United States: A Population-Based Study

  • by John L. Vaughn, Malak Munir, Ashley Cobb, Sravani Rimmalapudi, Narendranath Epperla

  • April 23, 2026

Related Content

Financial Hardship and Nonadherence to Lifestyle and Surveillance in Childhood Cancer Survivors

Emerging applications of artificial intelligence for risk stratification in head and neck cancer: a scoping review

Diffuse large B-cell lymphoma presenting as a scalp tumor with skull destruction and neurological symptoms: a case report